Healthcare -
Biotechnology - NASDAQ - US
$ 20.6
1.73 %
$ 3.5 B
Market Cap
-7.86
P/E
IMVT - TOTAL LIABILITIES
Total Liabilities IMVT - Immunovant, Inc.
48.6 M
LAST VALUE
3.09%
2 YEAR CAGR
163.80%
5 YEAR CAGR
0.00%
10 YEAR CAGR